Chimeric monoclonal antibodies to hypervariable region 1 of hepatitis C virus

Journal of General Virology

Volumn 86, Issue 6, 2005, Pages 1709-1716

  Li, Chengyao ^a   Allain, Jean Pierre ^b  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b East Anglia Blood Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN KAPPA CHAIN; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; BINDING AFFINITY; BINDING KINETICS; BIOTINYLATION; CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL INFECTION; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; LIVER TRANSPLANTATION; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; REINFECTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HUMANS; MICE; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; VIRAL PROTEINS;

HEPATITIS C VIRUS; MURINAE;

EID: 20044396574     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.80912-0     Document Type: Article

References (43)

1. Allender, T., Drakenberg, K., Beyene, A., Rosa, D., Abrignani, S., Houghton, M., Widell, A., Grillner, L. & Persson, M. A. A. (2000). Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81. J Gen Virol 81, 2451-2459.
2. Basu, A., Beyene, A., Meyer, K. & Ray, R. (2004). The hypervariable region 1 of the E2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype system. J Virol 78, 4478-4486.
3. Bruggemann, M., Williams, G. T., Bindon, C. I., Clark M. R., Walker, M. R., Jefferis, R., Waldmann, H. & Neuberger, M. S. (1987). Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med 166, 1351-1361.
4. Candotti, D., Temple, J., Sarkodie, F. & Allain, J.-P. (2003). Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J Virol 77, 7914-7923.
5. Casadevall, A., Dadachova, E. & Pirofski, L. A. (2004). Passive antibody therapy for infectious diseases. Nat Rev Microbiol 2, 695-703.
6. Cerino, A., Meola, A., Segagni, L., Furione, M., Marciano, S., Triyatni, M., Liang, T. J., Nicosia, A. & Mondelli, M. U. (2001). Monoclonal antibodies with broad specificity for hepatitis C virus hypervariable region 1 variants can recognize viral particles. J Immunol 167, 3878-3886.
7. Clark, M. (2000). Antibody humanization: a case of the 'Emperor's new clothes'? Immunol Today 21, 397-402.
8. Crabb, C. (2001). Hard-won advances spark excitement about hepatitis C. Science 294, 506-507.
9. Esumi, M., Ahmed, M., Zhou, Y.-H., Takahashi, H. & Shikata, T. (1998). Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus. Virology 251, 158-164.
10. Farci, P., Alter, H. J., Wong, D. C., Miller, R. H., Govindarajan, S., Engle, R., Shapiro, M. & Purcell, R. H. (1994). Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A 91, 7792-7796.
11. Farci, P., Shimoda, A., Wong, D. & 7 other authors (1996). Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A 93, 15394-15399.
12. Fried, M. W. & Hoofnagle, J. H. (1995). Therapy of hepatitis C. Semin Liver Dis 15, 82-91.
13. Furtado, P. B., McElveen, J. E., Gough, L., Armour, K. L., Clark, M. R., Sewell, H. F. & Shakib, F. (2002). The production and characterisation of a chimaeric human IgE antibody, recognising the major mite allergen Der p 1, and its chimaeric human IgG1 anti-idiotype. Mol Pathol 55, 315-324.
14. Gura, T. (2002). Magic bullets hit the target. Nature 417, 584-586.
15. Hamaia, S., Li, C. & Allain, J.-P. (2001). The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines. Blood 98, 2293-2300.
16. Jackson, P., Petrik, J., Alexander, G. J. M., Pearson, G. & Allain, J.-P. (1997). Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma. J Med Virol 51, 67-79.
17. Jones, P. T., Dear, P. H., Foote, J., Neuberger, M. S. & Winter, G. (1986). Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 321, 522-525.
18. Kabat, E. A., Wu, T. T., Perry, H. M., Gottesman, K. S. & Foeller, C. (1991). Sequences of Proteins of Immunological Interest, 5th edn. Bethesda, MD: US Department of Health and Human Services.
19. Köhler, G. & Milstein, C. (1975). Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495-497.
20. Korenaga, M., Hino, K., Katoh, Y., Yamaguchi, Y., Okuda, M., Yoshioka, K. & Okita, K. (2001). A possible role of hypervariable region 1 quasispecies in escape of hepatitis C virus particles from neutralization. J Viral Hepat 8, 331-340.
21. Kumar, U., Monjardino, J. & Thomas, H. C. (1994). Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobutinemic patient. Gastroenterology 106, 1072-1075.
22. Kurihara, C., Tsuzuki, Y., Hokari, R. & 7 other authors (2004). A highly hydrophobic domain within hypervariable region 1 may be related to the entry of hepatitis C virus into cultured human hepatoma cells. J Med Virol 74, 546-555.
23. Lavanchy, D. & McMahon, B. (2000). Worldwide prevalence and prevention of hepatitis C. In Hepatitis C, pp. 185-201. Edited by T. J. Liang & J. H. Hoofnagle. San Diego: Academic Press.
24. Li, C., Candotti, D. & Allain, J.-P. (2001). Production and characterization of monoclonal antibodies specific for a conserved epitope within hepatitis C virus hypervariable region 1. J Virol 75, 12412-12420.
25. McHutchison, J. G., Gordon, S. C., Schiff, E. R. & 7 other authors (1998). Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 339, 1485-1492.
26. Mondelli, M. U., Cerino, A., Lisa, A. & 11 other authors (1999). Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation. Hepatology 30, 537-545.
27. Mondelli, M. U., Cerino, A., Meola, A. & Nicosia, A. (2003). Variability or conservation of hepatitis C virus hypervariable region 1? Implications for immune responses. J Biosci 28, 305-310.
28. Penin, F., Combet, C., Germanidis, G., Frainais, P.-O., Deléage, G. & Pawlotsky, J.-M. (2001). Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J Virol 75, 5703-5710.
29. Petrik, J., Pearson, G. J. M. & Allain, J.-P. (1997). High throughput PCR detection of HCV based on semiautomated multisample RNA capture. J Virol Methods 64, 147-159.
30. Puntoriero, G., Meola, A., Lahm, A. & 9 other authors (1998). Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants. EMBO J 17, 3521-3533.
31. Ray, S. C., Wang, Y.-M., Laeyendecker, O., Ticehurst, J. R., Villano, S. A. & Thomas, D. L. (1999). Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy. J Virol 73, 2938-2946.
32. Rosa, D., Campagnoli, S., Moretto, C. & 11 other authors (1996). A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci U S A 93, 1759-1763.
33. Scarselli, E., Ansuini, H., Cerino, R. & 7 other authors (2002). The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21, 5017-5025.
34. Shang, D., Zhai, W. & Allain, J.-P. (1999). Broadly cross-reactive, high-affinity antibody to hypervariable region 1 of the hepatitis C virus in rabbits. Virology 258, 396-405.
35. Shimizu, Y. K., Hijikata, M., Iwamoto, A., Alter, H. J., Purcell, R. H. & Yoshikura, H. (1994). Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 68, 1494-1500.
36. Triyatni, M., Vergalla, J., Davis, A. R., Hadlock, K G., Foung, S. K. H. & Liang, T. J. (2002). Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding. Virology 298, 124-132.
37. van Doorn, L.-J., Capriles, I., Maertens, G., Deleys, R., Murray, K., Kos, T., Schellekens, H. & Quint, W. (1995). Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral responses. J Virol 69, 773-778.
38. Watanabe, K., Yoshioka, K., Ito, H. & 8 other authors (1999). The hypervariable region 1 protein of hepatitis C virus broadly reactive with sera of patients with chronic hepatitis C has a similar amino acid sequence with the consensus sequence. Virology 264, 153-158.
39. World Health Organization (1999). Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 6, 35-47.
40. Yanagi, M., Purcell, R. H., Emerson, S. U. & Bukh, J. (1997). Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci U S A 94, 8738-8743.
41. Zhai, W., Davies, J., Shang, D. Z., Chan, S. W. & Allain, J.-P. (1999). Human recombinant single-chain antibody fragments, specific for the hypervariable region 1 of hepatitis C virus, from immune phage-display libraries. J Viral Hepat 6, 115-124.
42. Zhou, Y.-H., Shimizu, Y. K. & Esumi, M. (2000). Monoclonal antibodies to the hypervariable region 1 of hepatitis C virus capture virus and inhibit virus adsorption to susceptible cells in vitro. Virology 269, 276-283.
43. Zibert, A., Schreier, E. & Roggendorf, M. (1995). Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 208, 653-661.